Conservative Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw in Multiple Myeloma Patients

The use of intravenous bisphosphonates (pamidronate or zoledronic acid) is the cornerstone for the management of multiple myeloma-(MM-) related bone disease. However, osteonecrosis of the jaw (ONJ) is a rare, but sometimes difficult to manage, adverse effect of bisphosphonates therapy. A retrospecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Melea, Pelagia I., Melakopoulos, Ioannis, Kastritis, Efstathios, Tesseromatis, Christina, Margaritis, Vasileios, Dimopoulos, Meletios A., Terpos, Evangelos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4087254/
https://www.ncbi.nlm.nih.gov/pubmed/25045353
http://dx.doi.org/10.1155/2014/427273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4087254/
https://www.ncbi.nlm.nih.gov/pubmed/25045353
http://dx.doi.org/10.1155/2014/427273

Ejemplares similares